We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
(-3.6%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.93B |
| 2 |
Kenvue
KVUE
|
+$537M |
| 3 |
Humana
HUM
|
+$477M |
| 4 |
AbbVie
ABBV
|
+$441M |
| 5 |
Microsoft
MSFT
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
Apple
AAPL
|
+$565M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$467M |
| 4 |
McKesson
MCK
|
+$347M |
| 5 |
Intel
INTC
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Consumer Staples | 7.45% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Texas Capital Bancshares
TCBI
$4.29B
| $2M | ﹤0.01% |
+34,039
| New | +$2.06M |
|
|
DPCSW
1202
CALL
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
| $2M | ﹤0.01% |
186,094
-7,743
| -4% | -$407 |
|
|
RENEW
1203
CALL
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
| $2M | ﹤0.01% |
185,385
-5,000
| -3% | -$835 |
|
1204
CALL
Broadcom
AVGO
$1.81T
| $1.99M | ﹤0.01% |
24,000
-22,000
| -48% | -$1.91M |
|
1205
Cognyte Software
CGNT
$644M
| $1.99M | ﹤0.01% |
414,085
+57,774
| +16% | +$293K |
|
|
SRDX
1206
DELISTED
Surmodics
SRDX
| $1.98M | ﹤0.01% |
61,744
+539
| +0.9% | +$18.3K |
|
|
NPABW
1207
CALL
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
| $1.98M | ﹤0.01% |
186,236
-6,837
| -4% | -$516 |
|
|
DOCU
1208
DocuSign
DOCU
$10.3B
| $1.97M | ﹤0.01% |
46,934
-161,621
| -77% | -$7.92M |
|
1209
Comtech Telecommunications
CMTL
$54.2M
| $1.96M | ﹤0.01% |
224,415
-91,183
| -29% | -$851K |
|
|
CLBTW
1210
CALL
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $1.96M | ﹤0.01% |
256,300
-81,376
| -24% | -$103K |
|
|
TGAAW
1211
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
| $1.96M | ﹤0.01% |
180,264
| – | – |
|
1212
Haemonetics
HAE
$3.65B
| $1.96M | ﹤0.01% |
21,848
-50,905
| -70% | -$4.54M |
|
1213
Curtiss-Wright
CW
$27B
| $1.94M | ﹤0.01% |
+9,929
| New | +$1.97M |
|
|
KAMN
1214
DELISTED
Kaman Corp
KAMN
| $1.94M | ﹤0.01% |
98,676
+65,297
| +196% | +$1.46M |
|
1215
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $1.94M | ﹤0.01% |
+26,300
| New | +$1.96M |
|
|
GCMGW
1216
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| $1.93M | ﹤0.01% |
248,512
+46,492
| +23% | +$14.6K |
|
1217
GoodRx Holdings
GDRX
$1.03B
| $1.93M | ﹤0.01% |
+342,496
| New | +$2.28M |
|
1218
NorthWestern Energy
NWE
$4.46B
| $1.92M | ﹤0.01% |
+39,976
| New | +$2.13M |
|
|
KC
1219
Kingsoft Cloud Holdings
KC
$2.96B
| $1.92M | ﹤0.01% |
389,444
+369,753
| +1,878% | +$2.09M |
|
|
HBI
1220
DELISTED
Hanesbrands
HBI
| $1.92M | ﹤0.01% |
484,083
+470,083
| +3,358% | +$2.28M |
|
1221
James River Group Holdings
JRVR
$221M
| $1.91M | ﹤0.01% |
124,598
-23,192
| -16% | -$378K |
|
1222
Harmonic Inc
HLIT
$1.21B
| $1.91M | ﹤0.01% |
197,880
+169,180
| +589% | +$2.02M |
|
|
SAFE
1223
Safehold
SAFE
$1.2B
| $1.9M | ﹤0.01% |
+107,016
| New | +$2.31M |
|
|
NUVL
1224
DELISTED
Nuvalent
NUVL
| $1.9M | ﹤0.01% |
+41,347
| New | +$1.84M |
|
1225
Regal Rexnord
RRX
$13.8B
| $1.9M | ﹤0.01% |
+13,300
| New | +$2.05M |
|
Similar funds
Marshall Wace's Q3 2023 Portfolio in Review
As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
- Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
- Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
- Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
- Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
- Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.